RNWL
INTERNATIONAL REGISTRATION RENEWED
04/09/2026
Back to search
Official data from USPTO
VIVAGEL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
58
Latest update
04/10/2026
Trademark type
Word
Nice classes
5, 10
Filing date
05/02/2016
Registration date
05/29/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/13/2024
Last transaction
04/10/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
82
Owner location
AU
Examiner
ALLEN, BIANCA LEIGH
Law office
N50
Current location
TMO LAW OFFICE 123
Holders and representatives
Holders
Starpharma Pty Ltd
Starpharma Pty Limited
Representatives
Starpharma Pty Limited
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceuticalspharmaceutical preparationspharmaceutical drugs for medical purposes for prevention of viral and bacterial diseasebacterial vaginosisherpes simplex virushuman papilloma virushuman immunodeficiency virus (HIV); chemical preparations for pharmaceutical and medical purposes for the prevention of bacterial vaginosisherpes simplex virushuman papilloma virus and human immunodeficiency virus (HIV); chemical compounds in the nature of antimicrobial or ph balancing or microbial balancing substances all for medical purposesfor treating and preventing vaginal microbial imbalancevaginal pH imbalancevaginal odor and dischargebacterial vaginosisviral STDvaginaitisvaginal thrushvaginal disease symptom relief including itchingodordischargefor maintaining a healthy balance of vaginal flora and for the reestablishment of the bacterial vaginal flora; polyvalent compounds and dendrimers sold as integral component parts of pharmaceuticals preparations all for medical purposes for the treatment and prevention of bacterial vaginosisherpes simplex virushuman papilloma virushuman immunodeficiency virus (HIV); antimicrobial preparationsmicrobicidal preparations in the nature of gelsfilmssolutionslubricants for vaginal and rectal use for prevention of bacterial vaginosisherpes simplex virushuman papilloma virushuman immunodeficiency virus (HIV); chemical contraceptivesspongesgelsfoamscreamsfilmssolutionssuspensions and lotions for use in preventing HIV and other sexually transmitted infections; prophylactic preparations for prevention of pregnancy and microbial disease of the reproductive systemchemical contraceptives and antibacterial preparations in the nature of spongessuppositoriessexual lubricantsgelsfoamscreamsfilmssolutionssuspensions and lotions; pharmaceutical preparations in the nature of vaginal gels and lubricants all for the prevention of pregnancy and sexually transmitted infections and diseases of the human reproductive system
Class 10
Contraceptive apparatusintravaginal cervical barriers; prophylactic instruments for use to prevent pregnancy and diseasecondomsdiaphragmsintrauterine devices
Publications
History of USPTO decisions and trademark events.
58 publications found
Further Decision Processed by IB
03/19/2026
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
02/04/2026
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
02/04/2026
XXCR
GENERIC MADRID TRANSACTION CREATED
02/04/2026
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
08/13/2025
C71T
CANCELLED SECTION 71
12/13/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
05/29/2023
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
06/07/2019
NREP
NEW REPRESENTATIVE AT IB RECEIVED
04/26/2019
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
12/08/2018
CORR
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
12/04/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/28/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/30/2018
ES7R
TEAS SECTION 7 REQUEST RECEIVED
10/30/2018
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/06/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/13/2018
FIMP
FINAL DISPOSITION PROCESSED
09/13/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/29/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
05/29/2018
GPNX
NOTIFICATION PROCESSED BY IB
03/16/2018
PUBO
PUBLISHED FOR OPPOSITION
03/13/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/21/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/21/2018
NPUB
NOTICE OF PUBLICATION
02/21/2018
EXPT
EXPARTE APPEAL TERMINATED
02/06/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/06/2018
CNEA
EXAMINERS AMENDMENT MAILED
02/06/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
02/06/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/06/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/23/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/23/2018
EXPI
EX PARTE APPEAL-INSTITUTED
01/22/2018
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
01/22/2018
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
01/22/2018
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
01/21/2018
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/27/2017
CNFR
FINAL REFUSAL MAILED
07/21/2017
CNFR
FINAL REFUSAL WRITTEN
07/20/2017
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
07/07/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/27/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/27/2017
ALIE
ASSIGNED TO LIE
06/23/2017
RFNT
REFUSAL PROCESSED BY IB
06/09/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/25/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/18/2017
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
04/28/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/10/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/09/2017
RFRR
REFUSAL PROCESSED BY MPU
02/09/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/09/2017
CNRT
NON-FINAL ACTION WRITTEN
02/08/2017
DOCK
ASSIGNED TO EXAMINER
02/06/2017
MAFR
APPLICATION FILING RECEIPT MAILED
12/20/2016
NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/16/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/15/2016
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
12/12/2016
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
12/01/2016
Continuous trademark protection
Get notified about every new filing that threatens VIVAGEL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.